Neogenomics (NEO) Share-based Compensation Growth (3y) (2013 - 2026)
Neogenomics (NEO) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.05% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 32.51% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.86% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.55% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 5.74% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -7.98% |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.52% |
| Dec 31, 2025 | 19.92% |
| Sep 30, 2025 | 34.03% |
| Jun 30, 2025 | 49.90% |
| Mar 31, 2025 | -3.86% |
| Dec 31, 2024 | -6.11% |
| Jun 30, 2024 | -64.59% |
| Mar 31, 2024 | 43.10% |
| Dec 31, 2023 | 37.72% |
| Mar 31, 2023 | 29.60% |
| Dec 31, 2022 | 27.06% |
| Sep 30, 2022 | 9.33% |
| Jun 30, 2022 | 16.17% |
| Mar 31, 2022 | 78.19% |
| Dec 31, 2021 | 77.25% |
| Sep 30, 2021 | 63.83% |
| Jun 30, 2021 | 24.54% |
| Mar 31, 2021 | 17.77% |
| Dec 31, 2020 | 62.04% |
| Sep 30, 2020 | -25.25% |